Related Experiment Video
Updated: Apr 27, 2026
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Effect of downregulated histone deacetylase 2 expression on cell proliferation and cell cycle in cervical cancer
Fangfang Hua1, Juan Sun, Fang Guo
1Department of Obstetrics and Gynecology, The First Affiliated Hospital of Xinxiang Medical University, Weihui, China.
Purpose:
To investigate the effects and molecular mechanism of downregulated histone deacetylase 2 (HDAC2) expression on cell proliferation and cell cycle in cervical cancer Hela cells.
Methods:
HDAC2 small interfering (si)RNA and control siRNA were transfected into cervical cancer Hela cells. A cell proliferation assay using a cell counting kit-8 was applied to analyze the change in cell proliferation before and after transfection. Flow cytometry was used to detect the change in cell cycle distribution before and after transfection. Finally, Western blot was used to detect changes in the expression of cell proliferation and cell cycle-related proteins.
Results:
HDAC2 siRNA significantly downregulated the expression of HDAC2 proteins in cervical cancer cells, markedly inhibiting their proliferation. In addition, the percentage of Hela cells in the G0/G1 phase in the HDAC2 siRNA group was 63.3±2.0%, significantly higher than those in the untreated group (29.3±1.7%) or the control siRNA group (29.4±1.7%) (F=354.181, p=0.000). Furthermore, Western blot analyses demonstrated that downregulated HDAC2 expression inhibited the expression of cyclin D1, cyclin E, and cdk2 proteins but elevated the expression of p21 protein.
Conclusion:
The proliferation inhibition and cell cycle arrest mediated by downregulated HDAC2 expression may be tightly associated with the decrease of cyclin D1, cyclin E, and cdk2 proteins expression and the increase in p21 protein expression.
Insights
Downregulating histone deacetylase 2 (HDAC2) in cervical cancer cells inhibits proliferation and arrests the cell cycle. This is linked to reduced cyclin D1, cyclin E, and cdk2, and increased p21 protein levels.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- Histone deacetylase 2 (HDAC2) plays a role in cancer progression.
- Understanding HDAC2's mechanism in cervical cancer is crucial for therapeutic development.
Purpose of the Study:
- To investigate the effects of reduced HDAC2 expression on cervical cancer cell proliferation and cell cycle.
- To elucidate the molecular mechanisms underlying these effects.
Main Methods:
- Transfection of Hela cells with HDAC2 siRNA.
- Cell proliferation assay (CCK-8).
- Flow cytometry for cell cycle analysis.
- Western blot for protein expression analysis.
Main Results:
- HDAC2 siRNA significantly inhibited Hela cell proliferation.
- HDAC2 downregulation led to cell cycle arrest at the G0/G1 phase.
- Reduced expression of cyclin D1, cyclin E, and cdk2, with increased p21 expression.
Conclusions:
- Downregulation of HDAC2 inhibits cervical cancer cell proliferation and induces cell cycle arrest.
- The mechanism involves modulation of cell cycle regulatory proteins (cyclin D1, cyclin E, cdk2, p21).
More Related Videos
Related Concept Videos
02:23Abnormal Proliferation
02:34Inhibition of Cdk Activity
02:34Inhibition of CDK Activity
01:27Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
01:23Negative Regulator Molecules
01:15Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...